Cerebrolysin: spectrum of activity and research data
The results of analysis of experimental and clinical studies have shown that Cerebrolysin application is safe and effective therapy for many neurological disorders ranging from stroke and ending Alzheimer’s disease. The primary effect of the medicine is associated with the influence of Cerebrolysin...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Federal State Budget Scientific Institution National Medical Research Center for Psychiatry and Neurology n.a. V.M. Bekhterev Ministry of Health of the Russian Federation
2018-07-01
|
| Series: | Обозрение психиатрии и медицинской психологии имени В.М. Бехтерева |
| Subjects: | |
| Online Access: | https://www.bekhterevreview.com/jour/article/view/171 |
| _version_ | 1797694688294076416 |
|---|---|
| author | N. D. Bukreeva E. A. Rakityanskaya |
| author_facet | N. D. Bukreeva E. A. Rakityanskaya |
| author_sort | N. D. Bukreeva |
| collection | DOAJ |
| description | The results of analysis of experimental and clinical studies have shown that Cerebrolysin application is safe and effective therapy for many neurological disorders ranging from stroke and ending Alzheimer’s disease. The primary effect of the medicine is associated with the influence of Cerebrolysin on certain areas of the hippocampus and their function. The medicine has a unique organ-multimodal action on the brain, it is capable of metabolic regulation, neuroprotection, functional neuromodulation and neurotrophic activity, detected in numerous experimental studies. The clinical efficacy of the medicine is confirmed by clinical trials performed based on GCP requirements. Side effects of the medicine are negligible. |
| first_indexed | 2024-03-12T03:01:28Z |
| format | Article |
| id | doaj.art-c2673b4ef3ce4cf8b0dd66ef5416c613 |
| institution | Directory Open Access Journal |
| issn | 2313-7053 2713-055X |
| language | Russian |
| last_indexed | 2024-03-12T03:01:28Z |
| publishDate | 2018-07-01 |
| publisher | Federal State Budget Scientific Institution National Medical Research Center for Psychiatry and Neurology n.a. V.M. Bekhterev Ministry of Health of the Russian Federation |
| record_format | Article |
| series | Обозрение психиатрии и медицинской психологии имени В.М. Бехтерева |
| spelling | doaj.art-c2673b4ef3ce4cf8b0dd66ef5416c6132023-09-03T14:46:02ZrusFederal State Budget Scientific Institution National Medical Research Center for Psychiatry and Neurology n.a. V.M. Bekhterev Ministry of Health of the Russian FederationОбозрение психиатрии и медицинской психологии имени В.М. Бехтерева2313-70532713-055X2018-07-01018996171Cerebrolysin: spectrum of activity and research dataN. D. Bukreeva0E. A. Rakityanskaya1ФГБУ «ФМИЦПН им. В.П. Сербского» Минздрава РоссииФГБУ «ФМИЦПН им. В.П. Сербского» Минздрава РоссииThe results of analysis of experimental and clinical studies have shown that Cerebrolysin application is safe and effective therapy for many neurological disorders ranging from stroke and ending Alzheimer’s disease. The primary effect of the medicine is associated with the influence of Cerebrolysin on certain areas of the hippocampus and their function. The medicine has a unique organ-multimodal action on the brain, it is capable of metabolic regulation, neuroprotection, functional neuromodulation and neurotrophic activity, detected in numerous experimental studies. The clinical efficacy of the medicine is confirmed by clinical trials performed based on GCP requirements. Side effects of the medicine are negligible.https://www.bekhterevreview.com/jour/article/view/171церебролизинлекарственная терапияпсихиатрияневрологияфармакологиянейропротекторметаболическая регуляцияфункциональная нейромодуляциянейротрофическая активностьcerebrolysinmedical therapypsychiatryneurologypharmacologyneuroprotectivemetabolic regulationfunctional neuromodulationneurotrophic activity |
| spellingShingle | N. D. Bukreeva E. A. Rakityanskaya Cerebrolysin: spectrum of activity and research data Обозрение психиатрии и медицинской психологии имени В.М. Бехтерева церебролизин лекарственная терапия психиатрия неврология фармакология нейропротектор метаболическая регуляция функциональная нейромодуляция нейротрофическая активность cerebrolysin medical therapy psychiatry neurology pharmacology neuroprotective metabolic regulation functional neuromodulation neurotrophic activity |
| title | Cerebrolysin: spectrum of activity and research data |
| title_full | Cerebrolysin: spectrum of activity and research data |
| title_fullStr | Cerebrolysin: spectrum of activity and research data |
| title_full_unstemmed | Cerebrolysin: spectrum of activity and research data |
| title_short | Cerebrolysin: spectrum of activity and research data |
| title_sort | cerebrolysin spectrum of activity and research data |
| topic | церебролизин лекарственная терапия психиатрия неврология фармакология нейропротектор метаболическая регуляция функциональная нейромодуляция нейротрофическая активность cerebrolysin medical therapy psychiatry neurology pharmacology neuroprotective metabolic regulation functional neuromodulation neurotrophic activity |
| url | https://www.bekhterevreview.com/jour/article/view/171 |
| work_keys_str_mv | AT ndbukreeva cerebrolysinspectrumofactivityandresearchdata AT earakityanskaya cerebrolysinspectrumofactivityandresearchdata |